Kenya: 37% of epilepsy medicines on sale are poor quality

The study by the Kenya Medical Research Institute (Kemri) and the University of Limoges, France, analyzed the quality of epilepsy medicines in Kenya, Madagascar and Gabon. The report published last week in the journal Epilepsia found some 32% of anti-epilepsy tablets in the three countries to be of poor quality: in Kenya, 37% of the medicines were of low quality and 34% in Madagascar and 26% in Gabon. The researchers collected 3,782 tablets and capsules from public, private and informal pharmaceutical outlets from the three countries.

Source :

Back to previous

Leave a Reply

Your email address will not be published. Required fields are marked *